FBXO38 expression based on
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison | Statistical significance |
Normal-vs-Primary | 1.20520038393579E-10 |
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
3.28439999996988E-06 |
Normal-vs-Stage2 |
1.995260E-04 |
Normal-vs-Stage3 |
N/A |
Normal-vs-Stage4 |
8.519400E-03 |
Stage1-vs-Stage2 |
3.450200E-01 |
Stage1-vs-Stage3 |
N/A |
Stage1-vs-Stage4 |
9.850200E-01 |
Stage2-vs-Stage3 |
N/A |
Stage2-vs-Stage4 |
4.402200E-01 |
Stage3-vs-Stage4 |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
3.22210003123047E-09 |
Normal-vs-AfricanAmerican |
5.96759999971219E-07 |
Normal-vs-Asian |
1.67765999999903E-05 |
Caucasian-vs-AfricanAmerican |
5.279900E-03 |
Caucasian-vs-Asian |
2.206400E-01 |
AfricanAmerican-vs-Asian |
1.008040E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
3.65930000001402E-06 |
Normal-vs-Female |
4.8909000005537E-07 |
Male-vs-Female |
3.692400E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient BMI information is not available for 1 sample.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
5.776600E-03 |
Normal-vs-Extreme_Weight |
4.24430000034448E-08 |
Normal-vs-Obese |
3.341900E-03 |
Normal-vs-Extreme_Obese |
N/A |
Normal_Weight-vs-Extreme_Weight |
1.671630E-01 |
Normal_Weight-vs-Obese |
7.096400E-02 |
Normal_Weight-vs-Extreme_Obese |
N/A |
Extreme_Weight-vs-Obese |
2.589400E-01 |
Extreme_Weight-vs-Extreme_Obese |
N/A |
Obese-vs-Extreme_Obese |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.10220000015815E-07 |
Normal-vs-Age(41-60Yrs) |
2.027300E-04 |
Normal-vs-Age(61-80Yrs) |
4.27869999986008E-07 |
Normal-vs-Age(81-100Yrs) |
1.191610E-04 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.630300E-02 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.536600E-03 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.622100E-02 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.209600E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.100800E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.433200E-01 |
|
|
CHOL : Cholangiocarcinoma
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
N/A |
Normal-vs-Grade 2 |
3.230400E-01 |
Normal-vs-Grade 3 |
2.737800E-01 |
Normal-vs-Grade 4 |
1.000000E+00 |
Grade 1-vs-Grade 2 |
N/A |
Grade 1-vs-Grade 3 |
N/A |
Grade 1-vs-Grade 4 |
N/A |
Grade 2-vs-Grade 3 |
9.497400E-01 |
Grade 2-vs-Grade 4 |
3.230400E-01 |
Grade 3-vs-Grade 4 |
2.737800E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 5 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
2.926999997932E-08 |
Normal-vs-N1 |
1.706340E-02 |
N0-vs-N1 |
5.387200E-01 |
|
|